6 results
Pain Assessment and Management Initiative (PAMI) - Opioid Prescribing and Equianalgesic Chart - Agents and Dosing

#Management
Management Initiative (PAMI ... Management #Pain #Pharmacology ... Equianalgesics #Conversion ... #Doses #Dosing ... #Table #PAMI
Angiotensin Receptor Blockers 
Recommended Dose Conversions 

Valsartan 
Irbesartan 
Losartan 
Olmesartan 
Telmisartan 
Candesartan 
Azilsartan 
Eprosartan 

A few
Recommended Dose Conversions ... dose of another drug ... recalls, this drug ... #Table #Dosing ... #Pharmacology #Dose
Antiplatelet Conversion - Switching Between P2Y12 Inhibitors
Oral P2Y12 inhibitors vary in potency and pharmacokinetic and dynamic
Antiplatelet Conversion ... P2Y12 inhibitors during ... Drug interactions ... Inhibitor #switching #conversion ... ticagrelor #prasugrel #pharmacology
Antiplatelet Conversion - Switching Between Oral P2Y12 Inhibitors
A, Switching between oral agents in the acute/early phase.
Antiplatelet Conversion ... dose of a given drug ... the timing and dosing ... dose of a given drug ... ticagrelor #prasugrel #pharmacology
IDSA Recommendations for Preventing and Treating Disseminated Mycobacterium Avium Complex in HIV-AIDS
Preventing 1st Episode of Disseminated
IDSA Recommendations ... please refer to Table ... 5 for dosing recommendation ... AviumComplex #MAC #IDSA ... infections #HIVAIDS #pharmacology
IDSA Recommendations for Treating Mycobacterium Tuberculosis Infection and Disease in HIV-AIDS
Treating LTBI (to prevent TB disease)
Indications:
IDSA Recommendations ... Please refer to the table ... Guidelines for dosing ... Tuberculosis #TB #IDSA ... infections #HIVAIDS #pharmacology